Metformin vs. Amaryl
See how Metformin and Amaryl compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Metformin is a biguanide that lowers blood sugar mainly by reducing liver glucose production and is the standard first choice for type 2 diabetes.
Amaryl (glimepiride) is a sulfonylurea that lowers blood sugar by prompting the pancreas to release more insulin, which raises hypoglycemia risk.
Doctors often start with metformin alone and add Amaryl later if blood sugar control needs more help.
Metformin vs. Amaryl Drug Summary
Metformin
Metformin is a biguanide used to control blood sugar in adults and children 10 and older with type 2 diabetes. It works by reducing how much glucose the liver releases and by improving the body's response to insulin. It comes as an immediate-release tablet, extended-release tablet, or oral solution, usually taken with meals.
Amaryl
Amaryl (glimepiride) is a sulfonylurea used along with diet and exercise to control blood sugar in adults with type 2 diabetes. It works by signaling the pancreas to release more insulin after meals. It is taken as a once-daily oral tablet, usually with breakfast or the first main meal.
Metformin vs. Amaryl Side Effects
Metformin
Amaryl
Metformin vs. Amaryl Dosage
Metformin
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 500 mg twice daily | Week 1 |
| Maximum dose | 500 mg once daily | Week 1 |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg or 2 mg once daily | At the start |
| Maximum dose | 1 mg or 2 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Metformin
| STAGE | DOSE | WHEN |
| Starting dose | 500 mg twice daily | Week 1 |
| Maximum dose | 500 mg once daily | Week 1 |
| Dose changes | 2 increases | As tolerated |
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg or 2 mg once daily | At the start |
| Maximum dose | 1 mg or 2 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Metformin vs. Amaryl Indications
Metformin
Metformin is FDA-approved to improve blood sugar control in adults and in children 10 and older with type 2 diabetes. It is also commonly prescribed off-label for polycystic ovary syndrome and for prediabetes or weight management, though these are not FDA-approved uses.
Type 2 diabetes in adults
Type 2 diabetes in children 10 and older
Off-label: polycystic ovary syndrome (PCOS)
Off-label: prediabetes or weight management
Amaryl
Amaryl is FDA-approved as an add-on to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also approved for combination use with insulin in patients whose blood sugar is not adequately controlled by either drug alone.
Type 2 diabetes in adults, with diet and exercise
Combination therapy with insulin when needed
Not approved for type 1 diabetes
Not approved for diabetic ketoacidosis
Metformin vs. Amaryl Pros and Cons
Metformin
Metformin has decades of use as the standard first-line drug for type 2 diabetes and carries a low risk of causing low blood sugar on its own. Its main drawbacks are gastrointestinal side effects and a boxed warning about a rare but serious buildup of lactic acid.
Pros
First-line therapy recommended by major diabetes guidelines
Low risk of hypoglycemia when used alone
Decades of long-term safety data
Also used off-label for PCOS and prediabetes
Cons
Gastrointestinal side effects are common, especially early on
Contraindicated in patients with severe kidney impairment
Carries a boxed warning for lactic acidosis
Must be paused before certain contrast dye procedures
Amaryl
Amaryl offers simple once-daily dosing and is the only sulfonylurea specifically approved for combination use with insulin. Its main trade-offs are a meaningful risk of low blood sugar and warnings about cardiovascular safety compared with diet alone.
Pros
Simple once-daily dosing schedule
Approved for combination use with insulin
Longer duration of action than older sulfonylureas
Effective add-on when metformin alone is not enough
Cons
Notable risk of hypoglycemia, including severe episodes
Warning about possible increased cardiovascular mortality risk
Postmarketing reports of serious hypersensitivity reactions
Not considered first-line therapy in current guidelines
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.